PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 19, 2026Biology of Reproduction0 citations

Simultaneous CRISPR-on activation of TFAP2C and SMARCA4 promotes development of trophoblast-fate cells in bovine embryos

View Full Paper
VAV. AlberioVSVirginia SavyMFM. Yauri Felipe

Key Points

  • The central aim is to assess the impact of simultaneous CRISPR-on activation of TFAP2C and SMARCA4 on trophoblast cell development in bovine embryos.
  • Conducted RNA microinjection to activate TFAP2C and SMARCA4 simultaneously.
  • Individually activated CDX2 and GATA3 through circular DNA microinjection.
  • Included control groups without small guide RNAs (sgRNAs) and non-injected embryos.
  • Analyzed gene expression levels and trophectoderm cell percentages at the blastocyst stage.
  • Simultaneous activation resulted in a significant increase in trophectoderm cells at the blastocyst stage.
  • RNA microinjection led to sustained expression of both TFAP2C and SMARCA4 beyond individual activation.
  • Individual activation of CDX2 and GATA3 effectively induced upstream genes but did not change trophectoderm percentages.
  • No significant differences in blastocyst production were observed compared to IVF controls.

Abstract

Abstract Assisted reproductive techniques are widely used to produce domestic animal embryos for commercial or research purposes. In cattle, abnormal trophoblast cell differentiation during embryo development causes pregnancy and placentation failures. The CRISPR-on system has been successfully used in bovine embryos to individually activate early trophoblast lineage genes TFAP2C and SMARCA4. This study evaluates the effect of CRISPR-on activation of early and advanced trophoblast-related genes in bovine zygotes to promote trophectoderm differentiation. In one experiment, RNA was microinjected to simultaneously activate TFAP2C and SMARCA4; in another, circular DNA was microinjected to induce CDX2 or GATA3 expression separately. Controls included groups without small guide RNAs (sgRNAs, SHAM) and non-injected embryos (IVF). RNA microinjection transiently and simultaneously increased TFAP2C, SMARCA4, and downstream gene expression, producing a prolonged effect beyond individual gene activation. This led to a significant increase in trophectoderm cells at the blastocyst stage. Individual activation of CDX2 and GATA3 was effective, also inducing upstream genes without altering trophectoderm cell percentages. Neither RNA nor DNA microinjection affected blastocyst production compared to IVF. This work demonstrates the successful increase of trophoblast cells in bovine embryos using CRISPR-on, offering a useful strategy for IVF or SCNT embryos. The CRISPR-dCas9VP160 system may also aid understanding of trophoblast lineage signaling during development.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Alberio et al. (2026) studied this question.

synapsesocial.com/papers/6996a8c7ecb39a600b3efe5fhttps://doi.org/10.1093/biolre/ioag041
Ask AI
Helpful
Bookmark
Share
View Full Paper